Alkermes ALKS Medicare Part D — Accrued Sales Discounts Allowances And Reserves

Similar metrics at other companies

JAK

JAKKSales Reserves Allowances

$26.74M+1.9%

KNXEmployee medical reserves — Accrued Insurance

$33.5M+34.7%

RKTReserves and discounts

$135M—

RKTReserves and discounts

$135M—

RGRProduct Liability Reserve — Valuation Allowances And Reserves Balance

$1.03M+108%

SRPTPayments Credits Reserves For Discounts And Allowances

$130.87M—

FAQ

What is Alkermes's medicare part d — accrued sales discounts allowances and reserves?

Alkermes (ALKS) reported medicare part d — accrued sales discounts allowances and reserves of $30.8M in Q2 2026.

How has Alkermes's medicare part d — accrued sales discounts allowances and reserves changed year-over-year?

Alkermes's medicare part d — accrued sales discounts allowances and reserves increased by 28.8% year-over-year, from $23.91M to $30.8M.

What is the long-term trend for Alkermes's medicare part d — accrued sales discounts allowances and reserves?

Over 3 years (2022 to 2025), Alkermes's medicare part d — accrued sales discounts allowances and reserves has grown at a 10.4% compound annual growth rate (CAGR), from $66.51M to $89.47M.

What does medicare part d — accrued sales discounts allowances and reserves mean?

This metric represents the estimated financial obligations and contra-revenue reserves specifically associated with Medicare Part D coverage for the company's pharmaceutical products. It accounts for anticipated rebates, discounts, and coverage gap liabilities that the company expects to pay to government programs or pharmacy benefit managers. These accruals are essential for accurately reporting net revenue by adjusting gross sales for expected future price concessions.